News

Cenix BioScience Signs Research Service Agreement with Bayer Pharma AG

Published: May 6, 2014

News

Cenix BioScience Signs Research Service Agreement with Bayer Pharma AG

Published: May 6, 2014

Read time:

Want a FREE PDF version of This News Story?

Complete the form below and we will email you a PDF version of "Cenix BioScience Signs Research Service Agreement with Bayer Pharma AG"

First Name*

Last Name*

Email Address*

Country*

Company Type*

Job Function*

Would you like to receive further email communication from Technology Networks?

Technology Networks Ltd. needs the contact information you provide to us to contact you about our products and services. You may unsubscribe from these communications at any time. For information on how to unsubscribe, as well as our privacy practices and commitment to protecting your privacy, check out our Privacy Policy

Cenix BioScience GmbH (Cenix) has announced that is has signed a research service agreement with Bayer Pharma AG (Bayer).

Under the agreement, Cenix will undertake a target discovery project for an undisclosed disease indication by applying its longstanding industry-leading expertise in high throughput RNAi for genome-scale screening in advanced cell models.

Financial terms were not disclosed.

Chosen for You